This datum indicates that the presence of IL-17 within its receptor (IL-17R) is a favorable prognostic factor in the modulation of the pathogenesis of IBD, diminishing the activation of T-cells in TH1 sense. The gene discussed is IL17A; the disease is inflammatory bowel disease.